• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Adrenoleukodystrophy

Adrenoleukodystrophy - 27 Studies Found

Completed : Newborn Screening for Adrenoleukodystrophy
: Adrenoleukodystrophy
: 2016-10-31
: Procedure: newborns testing for ALD Routine newborn screening dried blood spots sample is used to test i
Withdrawn : MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
: Cerebral Adrenoleukodystrophy
: 2015-03-27
: Biological: Mesenchymal Stem Cells
Suspended : Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
: Adrenoleukodystrophy
: 1999-10-18
:
  • Drug: glyceryl trierucate Glyc

Available : Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
: X-linked Adrenoleukodystrophy
: 2014-05-05
: Drug: Lorenzo's Oil Oral use of Lorenzo's oil to lower very long chain fatty acids
Completed : Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
: Adrenoleukodystrophy
: 2006-01-16
: Procedure: blood sampling and medical records
Completed : A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
: Cerebral Adrenoleukodystrophy (CALD)
: 2013-03-22
: Genetic: Lenti-D Drug Product Lenti-D Drug Product (autologous CD34+ cell-enriched population that conta
Completed : A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
: X-linked Adrenoleukodystrophy
: 2015-10-29
: Dietary Supplement: vitamin D3 Daily oral supplement provided by study investigators
Completed : The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)
:
  • X-linked Adrenoleukodystrophy
  • Adrenomyelo
    : 2010-07-13
    : Drug: Bezafibrate Week 0 to 12: 400 mg once daily 1 tablet. Week 13 to 24: 400 mg once daily 2 tablets.
Withdrawn : Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
:
  • X-Linked Adrenoleukodystrophy
  • Adrenomyelo
    : 2013-02-06
    : Drug: Sobetirome 50 mcg or 100 mcg once-daily oral O
Terminated : A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
:
  • Adrenomyeloneuropathy
  • Adrenoleukodystroph
    : 2007-10-16
    : Drug: Lorenzo's oil 4:1 glyceryl trioleate-glyceryl trierucate (Lorenzo's oil)given orally, daily as app
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.